This is a $6,606.71 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a period of performance through July 8, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a $1,134.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a performance period ending on June 11, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $9,156.97 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical vaccine product. The award is part of Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This is a $18,827.91 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a period of performance through February 11, 2025. The contract is an open competition award with no set-aside designation. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This is a $2,663.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a type of vaccine, with a period of performance through February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a $1,379.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product, with an ultimate completion date of July 9, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and this...
This is a $3,098.79 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a performance period through July 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a $2,808.93 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a completion date of June 7, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $74,904.80 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is to deliver TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract is not designated with a set-aside. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a $9,496.19 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a performance period ending on June 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...